| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 11 |
| 1 | ASPIRIN 325 MG | 11 |
| 2 | ASPIRIN 81 MG | 11 |
| 3 | FUROSEMIDE | 9 |
| 4 | ACETAMINOPHEN | 8 |
| 5 | ADALIMUMAB | 8 |
| 6 | IBRUTINIB | 8 |
| 7 | UPADACITINIB | 8 |
| 8 | AMBRISENTAN | 7 |
| 9 | CLOPIDOGREL | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MIGALASTAT HYDROCHLORIDE | 1 | 0.0018 |
| 1 | SIBEPRENLIMAB | 1 | 0.0015 |
| 2 | PSYLLIUM HUSK | 1 | 0.0007 |
| 3 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL | 1 | 0.0006 |
| 4 | PEGCETACOPLAN | 1 | 0.0005 |
| 5 | RANOLAZINE | 4 | 0.0004 |
| 6 | PATISIRAN | 1 | 0.0004 |
| 7 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 8 | VUTRISIRAN | 1 | 0.0003 |
| 9 | BARICITINIB | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 2 | Loop Diuretic [EPC] | 10 |
| 3 | Kinase Inhibitor [EPC] | 9 |
| 4 | Endothelin Receptor Antagonist [EPC] | 8 |
| 5 | Janus Kinase Inhibitor [EPC] | 8 |
| 6 | Benzodiazepine [EPC] | 7 |
| 7 | Osmotic Laxative [EPC] | 7 |
| 8 | Expectorant [EPC] | 6 |
| 9 | Proton Pump Inhibitor [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-anginal [EPC] | 4 | 0.0004 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | Non-narcotic Antitussive [EPC] | 2 | 0.0001 |
| 4 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |
| 5 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 7 | Bile Acid Sequestrant [EPC] | 1 | 0.0001 |
| 8 | Potassium-sparing Diuretic [EPC] | 1 | 0.0001 |
| 9 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |